Assenagon Asset Management S.A.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1546007
SENNINGERBERG, N4
Position in NBIX
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$12,051,311
+$703,210 QoQ
Shares Held
91,478
+14.3% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Assenagon Asset Management S.A. holds $291,766,020 across 19 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
815,412 | $96,389,852 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,339,702 | $40,351,824 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
3,067,361 | $38,127,297 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
47,183 | $27,978,575 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
530,618 | $27,427,644 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
This page
|
91,478 | $12,051,311 | |
| 7 | VTRS |
Viatris Inc
|
783,134 | $10,580,140 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
312,598 | $10,337,615 |
All Filings in NBIX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,051,311 | 91,478 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $11,348,101 | 80,012 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $6,590,419 | 46,947 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $7,569,931 | 60,227 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $43,516,123 | 393,455 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $3,568,110 | 26,140 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $3,433,901 | 29,803 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $34,338,202 | 249,424 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $46,580,687 | 337,737 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $41,578,185 | 315,560 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $65,760,637 | 584,539 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $24,987,142 | 264,975 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $9,161,219 | 90,508 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $24,894,998 | 208,431 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $9,008,519 | 84,818 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $13,595,633 | 139,471 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $1,299,375 | 13,860 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $7,309,715 | 85,825 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,073,328 | 11,191 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $4,775,395 | 49,069 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $314,409 | 3,233 | Shares | Sole | 2021-04-26 | |
| 2020-06-30 | $2,796,972 | 22,926 | Shares | Sole | 2020-07-21 | |
| No filing history on record for this holder in this stock. | ||||||